GlassScriptPhysician profile
Ayman Soubra
NPI 1689053993
$204,394.95
in general payments reported to CMS, 2019-2025
42 companies · $1,841 in 2025
The $1,841 reported for 2025 was more than what 78% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,278 · 2020: $143K · 2021: $47K · 2022: $6,541 · 2023: $1,175 · 2024: $2,680 · 2025: $1,841.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,060 · Travel and Lodging: $637.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,059.55 |
| Travel and Lodging | $636.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $143,476.44 | 2020-2024 | Xiaflex, Aveed, Edex |
| Boston Scientific Corporation | $53,626.55 | 2019-2025 | Ams 800 Artificial Urinary Sphincter, Ams 700, General - Female Sui |
| Coloplast Corp | $2,583.44 | 2020-2024 | Titan |
| Endo USA, INC. | $847.33 | 2024-2025 | Xiaflex, Aveed, Edex |
| Sumitomo Pharma America, INC. | $439.35 | 2023-2025 | Orgovyx, Gemtesa |
| Teleflex LLC | $388.50 | 2022-2025 | Barrigel |
| Abbvie INC. | $370.66 | 2022-2025 | Botox, Lupron Depot |
| Pfizer INC. | $215.66 | 2022-2025 | |
| Astellas Pharma US INC | $197.89 | 2021-2025 | Xtandi, Myrbetriq |
| Janssen Biotech, INC. | $193.65 | 2021-2025 | Erleada |
| Antares Pharma, INC. | $169.67 | 2021-2023 | Xyosted, Tlando |
| Merck Sharp & Dohme LLC | $156.30 | 2023-2025 | Keytruda, Welireg, Lynparza |
| Novartis Pharmaceuticals Corporation | $139.62 | 2022-2025 | |
| Ferring Pharmaceuticals INC. | $113.53 | 2024 | Adstiladrin |
| Progenics Pharmaceuticals, INC. | $104.19 | 2022-2025 | Pylarify |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $97.82 | 2023 | Prolaris |
| Olympus America INC. | $93.07 | 2020-2025 | Itind System |
| Dendreon Pharmaceuticals LLC | $91.01 | 2023-2025 | Provenge |
| Axonics, INC. | $88.39 | 2022-2024 | Bulkamid |
| Baxter Healthcare | $85.32 | 2024-2025 | Floseal, Tisseel |
| Medtronic, INC. | $84.50 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $77.66 | 2021-2025 | |
| Urogen Pharma, INC. | $77.65 | 2023-2025 | Jelmyto |
| Convatec INC. | $77.36 | 2025 | |
| Telix Pharmaceuticals | $75.28 | 2023-2025 | Illuccix |
| Laborie Medical Technologies Corp. | $74.25 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Tolmar, INC. | $65.75 | 2025 | Jatenzo, Eligard |
| Hollister Incorporated | $47.03 | 2022-2023 | Vapro Plus Pocket |
| Blue Earth Diagnostics | $43.81 | 2025 | Posluma |
| Cook Medical LLC | $43.11 | 2024-2025 | Litho 150 |
| Innovation Technologies INC | $36.67 | 2025 | Irrisept |
| Cardinal Health 414 LLC | $30.86 | 2025 | |
| Verity Pharmaceuticals INC. | $24.78 | 2025 | Tlando |
| Karl Storz Endoscopy-America | $24.31 | 2025 | |
| Myovant Sciences INC. | $22.29 | 2022 | |
| Clarus Therapeutics INC. | $20.69 | 2021 | |
| Ambu INC. | $20.54 | 2022 | |
| Sun Pharmaceutical Industries INC. | $15.51 | 2025 | |
| Dentsply Ih INC. | $15.08 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $13.76 | 2022 | |
| Bluewind Medical | $13.70 | 2024 | Revi |
| Acerus Pharmaceuticals Corporation | $11.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ayman Soubra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.